OPRK1 and chronic kidney disease: Reduced KOR expression in the skin of CKD-aP patients correlates inversely with itch severity, underscoring a pathogenic role of impaired KOR signaling and establishing a clear biological indication for KOR agonist therapy (Wieczorek et al., 2020).